Detalhe da pesquisa
1.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
N Engl J Med;
387(16): 1445-1455, 2022 10 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36260792
2.
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3â years of treatment in randomized phase III trials.
Br J Dermatol;
190(4): 477-485, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37950894
3.
Spirituality/Religion Among First Responders With and Without Posttraumatic Stress Disorder and Alcohol Misuse.
J Dual Diagn;
: 1-12, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38560884
4.
Effects of religion on the course of suicidality among geriatric patients with mood disorders.
Psychol Med;
53(10): 4446-4453, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35545890
5.
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials.
Br J Dermatol;
188(6): 740-748, 2023 05 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36994947
6.
Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm.
Br J Dermatol;
190(1): 62-69, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37615581
7.
Spirituality/Religion and Self-Harm Among Patients With Alcohol/Substance Use Versus Other Disorders.
J Nerv Ment Dis;
211(8): 566-571, 2023 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37015109
8.
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
J Eur Acad Dermatol Venereol;
37(11): 2173-2184, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37746876
9.
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.
J Eur Acad Dermatol Venereol;
37(11): 2185-2195, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37715487
10.
Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE).
J Drugs Dermatol;
22(4): 425-427, 2023 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37026882
11.
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting.
J Drugs Dermatol;
22(12): 1153-1159, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38051841
12.
Religious affiliation protects against alcohol/substance use initiation: A prospective study among healthy adolescents.
J Adolesc;
95(2): 372-381, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36345114
13.
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results.
J Allergy Clin Immunol;
149(3): 977-987.e14, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34403658
14.
Religious Beliefs, Trust In Public Figures, And Adherence to COVID-19 Health Guidelines among American Orthodox and Non-Orthodox Jews.
J Relig Health;
62(1): 355-372, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36517731
15.
Review of the Cardiovascular Implications of the Social and Religious Practices Associated with Donning Phylacteries.
J Relig Health;
62(1): 287-299, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35028811
16.
Usage of Topical Calcineurin Inhibitors in the Medicare Population from 2013 to 2018.
J Drugs Dermatol;
21(8): 912-913, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35946970
17.
A Potential Alternative Treatment for Vitiligo: An Observational Study on Tacrolimus 0.3% Lotion.
J Drugs Dermatol;
21(12): 1370-1371, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36468953
18.
International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting.
J Drugs Dermatol;
21(8): 867-874, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35946973
19.
Onset of Symptom Relief Reported in Daily Diaries of Patients With Atopic Dermatitis Treated With Baricitinib in a United States Clinical Trial (BREEZE-AD5).
J Cutan Med Surg;
26(3): 262-266, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35086348
20.
Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in Adult Patients With Moderate-to-Severe Atopic Dermatitis From a Double-Blind, Placebo-Controlled Baricitinib Phase 3 Study.
J Cutan Med Surg;
26(4): 377-385, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35354410